Intrinsiqs

Is Artiva Biotherapeutics, Inc. overvalued?

Artiva Biotherapeutics, Inc. (ARTV) — key valuation metrics and fundamentals.

No verdict
Price
$11.45
Fair value
Current P/E
Normal P/E
Market cap
$559.8M
Dividend yield
0.0%
Return on equity
-53.9%
Sector
Healthcare

See the full interactive analysis →

Fair value compares ARTV's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 11 Aug 2026.